Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Erythropoietin: a new perspective in cardiovascular therapy].
Raddino R, Robba D, Caretta G, Bonadei I, Teli M, Zanini G, Madureri A, Vizzardi E, Dei Cas L. Raddino R, et al. Monaldi Arch Chest Dis. 2008 Dec;70(4):206-13. doi: 10.4081/monaldi.2008.414. Monaldi Arch Chest Dis. 2008. PMID: 19263796 Review. Italian.
Biological drugs: classic adverse effects and new clinical evidences.
Della Pina P, Vizzardi E, Raddino R, Gavazzoni M, Caretta G, Gorga E, Dei Cas L. Della Pina P, et al. Among authors: raddino r. Cardiovasc Toxicol. 2012 Dec;12(4):285-97. doi: 10.1007/s12012-012-9173-z. Cardiovasc Toxicol. 2012. PMID: 22661099 Review.
Elastic aortic properties in patients with X syndrome.
Vizzardi E, Trichaki E, Bonadei I, Sciatti E, Salghetti F, Raddino R, Metra M. Vizzardi E, et al. Among authors: raddino r. Heart Lung Circ. 2014 Feb;23(2):114-8. doi: 10.1016/j.hlc.2013.07.009. Epub 2013 Aug 22. Heart Lung Circ. 2014. PMID: 23972720 Clinical Trial.
Reply: To PMID 24708382.
Bonadei I, Vizzardi E, D'Aloia A, Sciatti E, Raddino R, Metra M. Bonadei I, et al. Among authors: raddino r. J Clin Hypertens (Greenwich). 2014 Sep;16(9):694. doi: 10.1111/jch.12357. Epub 2014 Jun 12. J Clin Hypertens (Greenwich). 2014. PMID: 24919601 Free PMC article. No abstract available.
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: Early in vivo cardiovascular effects.
Gavazzoni M, Lombardi CM, Vizzardi E, Gorga E, Sciatti E, Rossi L, Belotti A, Rossi G, Metra M, Raddino R. Gavazzoni M, et al. Among authors: raddino r. Eur J Pharmacol. 2018 Nov 5;838:85-90. doi: 10.1016/j.ejphar.2018.09.014. Epub 2018 Sep 7. Eur J Pharmacol. 2018. PMID: 30201379 Free article.
118 results